February 6, 2014

The National Association of Boards of Pharmacy, along with a coalition of healthcare industry stakeholders, on Wednesday issued a consensus statement regarding the collaborative steps that will be taken to help ensure the delivery of responsible and effective patient care as it relates to the prescribing and dispensing of controlled substances.

February 6, 2014

McKesson confirmed that it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio shares.

February 6, 2014

The Food and Drug Administration’s proposed rule on prescription drug labeling would add $4 billion annually to the nation’s healthcare costs, undercutting the cost savings that generic medicines have brought to America’s patients and healthcare system, according to an analysis released Wednesday by economic consulting firm Matrix Global Advisors.

February 6, 2014

The Associated Press on Tuesday reported that New York's online database of drug prescriptions has curtailed "doctor shopping" by 75%, citing New York Health Commissioner Nirav Shah.

February 6, 2014

Sandoz announced the launch of doxercalciferol injection vials, the first generic version of Genzyme’s Hectorol.

February 5, 2014

The Centers for Disease Control and Prevention published an updated "Immunization Schedule for Adults Aged 19 Years or Older, 2014," in the Morbidity and Mortality Weekly Report.

February 3, 2014

Endo Health Solutions on Monday announced that its Qualitest subsidiary has completed the acquisition of privately-held Boca Pharmacal, a specialty pharmaceutical company, for approximately $225 million in cash.

February 3, 2014

The Food and Drug Administration is investigating the risk of stroke, heart attack and death in men taking FDA-approved testosterone products, the agency announced Friday.

February 3, 2014

The Generic Pharmaceutical Association on Monday identified its key priorities for 2014 — guarding against confusion a proposed labeling change would cause; gaining access to biosimilar generics; and heralding the cost savings generated by generic utilization.

February 3, 2014

Mylan on Monday announced that its subsidiary has launched the world's first trastuzumab biosimilar in India, which will be marketed by Mylan as Hertraz.

February 3, 2014

A desire to provide an integrated continuum of care that leads to improved outcomes and patient satisfaction has placed a renewed focus on U.S. hospitals offering on-campus retail pharmacies, according to a report by HealthLeaders Media.

February 3, 2014

Approximately 1-in-3 chronically-ill National Health Interview Survey participants are unable to afford food, medications or both, according to a study published Jan. 21 in the American Journal of Medicine.

February 3, 2014

In support of American Heart Month, Walgreens is offering free blood-pressure testing at all of its pharmacies and Healthcare Clinics throughout the month of February, the retailer announced Monday.

January 31, 2014

Actavis on Friday announced a realignment of its global strategic business structure to maximize the company's newly strengthened position as a leading specialty pharmaceutical developer, manufacturer and marketer, and to enhance Actavis' position for continued long-term growth.

January 31, 2014

The imminent entry of several companies — including big pharma, small biotech and generic participants — into the global biosimilars space will propel the market toward exponential growth. The market is expected to soar from $1.2 billion in 2013 to $24 billion in 2019, reported Frost & Sullivan in research released earlier this week.

January 31, 2014

Following the announcement that Rep. Henry Waxman, D-Calif., intended to retire, the Generic Pharmaceutical Association bid adieu to a legislator who had a tremendous positive impact on the generic industry.

January 31, 2014

The Biotechnology Industry Organization and the Indiana Health Industry Forum commended the Indiana Senate for passing legislation designed to create a pathway for the substitution of interchangeable biologic medicines.

January 31, 2014

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

Nothing good is ever easy. "While the path to securing this acquisition was certainly not what we had originally expected, it would seem that the interested parties to this transaction continued to see the compelling strategic benefit of McKesson and Celesio uniting to form a global leader in health care services," John Hammergren, McKesson chairman, CEO and president, said of the deal. "I never lost sight of the value this transaction will bring to our customers, our supply chain partners, the employees of both organizations and our shareholders."

January 30, 2014

Rite Aid's January same-store sales increased 1.8%, beating out an analyst projection of a 0.5% increase in overall comparable-store sales. Total drug store sales for the four weeks ended Jan. 25 increased 1.5% to $1.9 billion.

January 28, 2014

Actavis announced that it has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co. to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., an Actavis subsidiary based in Foshan, China.

January 28, 2014

Pharmacists and nurse practitioners are trusted healthcare professionals who provide instructions and advice based on peer-reviewed guidelines and clinical data.

January 28, 2014

In 2012, compounding made headlines when 64 people died as a result of fungal meningitis caused by contaminated compounded products.

January 28, 2014

Americans by and large have lousy diets, pharmacist and supplement expert James LaValle, CEO of Integrative Health Resources, told DSN Collaborative Care recently. Over a lifetime, those nutrient-poor diets contribute to the development of such chronic disease states as obesity, hypertension and diabetes.

January 28, 2014

What’s at the root of most morbidity and mortality from influenza and other vaccine-preventable diseases? Under-immunization.